SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

26 hedge funds and large institutions have $11.9M invested in Seelos Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

Holders
26
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.65M
2
+$256K
3
+$249K
4
DC
Davenport & Co
Virginia
+$216K
5
Renaissance Technologies
Renaissance Technologies
New York
+$176K

Top Sellers

1
-$468K
2
-$164K
3
-$135K
4
AAP
Ardsley Advisory Partners
Connecticut
-$75K
5
TSS
Two Sigma Securities
New York
-$24K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4.74K
27
$2K
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
1
2